The Cancer Liquid Biopsy market is a subset of the Diagnostics industry that focuses on the use of liquid biopsies to detect and monitor cancer. Liquid biopsies are non-invasive tests that use a sample of blood, urine, or other bodily fluid to detect cancer cells or genetic material associated with cancer. This type of biopsy can provide information about the type and stage of cancer, as well as the presence of mutations that may affect treatment options. Liquid biopsies are increasingly being used to monitor cancer progression and response to treatment, as well as to detect cancer recurrence. Some companies in the Cancer Liquid Biopsy market include Guardant Health, Exosome Diagnostics, Freenome, and Biocept. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
